The Ministry of Health (MoH) of the Republic of Trinidad and Tobago has issued an alert regarding falsified IBRANCE (palbociclib) capsules, a medicine used in treating specific types of breast cancer. The Ministry’s Chemistry, Food and Drugs Division (CFDD) has advised the public about a WHO alert concerning these counterfeit products. The fake products misrepresent their origins, composition, and identity. Pfizer, the original manufacturer, has confirmed the falsified nature of these products. These counterfeit medicines have been detected in Côte d’Ivoire, Egypt, Lebanon, Libya, and Türkiye. The falsified capsules contain no active pharmaceutical ingredient, making them unsafe for consumption. Using these can lead to treatment failure, uncontrolled cancer progression, and a higher risk of death. The Ministry advises individuals who might have these drugs to stop using them immediately and return them to the place of purchase. The counterfeit products display multiple packaging discrepancies and capsule irregularities.
Join the Trinidad and Tobago WhatsApp update group: https://chat.whatsapp.com/DKueX7ZV35626FbOsKBt03
Follow us on Instagram: @news.tringlobe
Caribbean Aviation Authorities Investigate Mysterious Aircraft Disappearance
Guyana has introduced a new news channel aimed at providing balanced coverage and timely information…
Dr. Niven Narain, a Guyana-born American biotech innovator, is establishing a women's health foundation aimed…
Authorities in Jamaica are investigating a hit-and-run incident that resulted in the death of a…
Primary school student recognized for returning found money
Dashcam records alleged robbery attempt against rideshare driver